Researchers in Japan have reported encouraging findings from the first [...]

As global pharma grapples with shifting regulations, rising geopolitical tensions, [...]

Axplora has confirmed the successful outcome of its latest inspection [...]

The US Food and Drug Administration (FDA) has unveiled Elsa, [...]

Stephan Ohnmacht, VP of R&D Business Consulting at Veeva Systems, [...]

At a roundtable during the Veeva Summit being held in [...]

In a keynote address that signaled both reflection and momentum, [...]

As psychedelic-assisted therapies move closer to mainstream psychiatric care, Cybin, [...]

MaaT Pharma has submitted a marketing authorisation application (MAA) to [...]

Protagonist and Takeda have shared full 32-week results from the [...]